国际移植与血液净化杂志
國際移植與血液淨化雜誌
국제이식여혈액정화잡지
INTERNATIONAL JOURNAL OF TRANSPLANTATION AND HEMOPURIFICATION
2010年
1期
31-34
,共4页
付虹辉%孙欣%朱万军%张淼%刘书明%张鹏%李艳君
付虹輝%孫訢%硃萬軍%張淼%劉書明%張鵬%李豔君
부홍휘%손흔%주만군%장묘%류서명%장붕%리염군
血液预冲%血液灌流联合血液透析%重症心力衰竭合并肾功能衰竭
血液預遲%血液灌流聯閤血液透析%重癥心力衰竭閤併腎功能衰竭
혈액예충%혈액관류연합혈액투석%중증심력쇠갈합병신공능쇠갈
Pre-rinsing with whole blood%Hemoperfusion combined with hemodialysis%Heart failure complicated renal failure
目的 探讨重症心力衰竭合并肾功能衰竭应用全血预冲透析管路后血液灌流联合血液透析治疗后的疗效.方法 选择2007年6月至2009年6月牡丹江市第一人民医院肾内科和心内一科重症心力衰竭合并肾功能衰竭患者48例.应用全血预冲透析管路后血液灌流联合血液透析治疗.每天1次,连续3 d.每次治疗前、后分别观察患者动脉血气分析(碳酸氧根离子、pH值、动脉血氧饱和度、动脉血氧分压、肾功能(血尿素氮、血肌酐)、血红蛋白、呼吸、心率、平均动脉压、中心静脉压水平.治疗前和第3次治疗后分别观察患者腩钠素、肿瘤坏死因子α水平及左室舒张未期内径、左室收缩末期内径、左室射血分数.结果 治疗过程中患者生命指标和血流动力学稳定.全部患者在治疗期间无一例死亡.治疗过程中生命指征平稳,第1次治疗后呼吸、心率、血红蛋白、中心静脉压、碳酸氢根离子、pH值、动脉血氧饱和度、动脉血氧分压、血尿素氮、血肌酐指标比较差异有统计学意义(P<0.05);平均动脉压治疗前、后比较差异无统计学意义(P>0.05);肺部湿啰音明显减少,尿最逐渐增加.经3次治疗后脑钠素、肿瘤坏死因子α水平显著下降,左室舒张末期内径、左室收缩末期内径、左室射血分数显著改善(P<0.01).结论 血液预冲透析管路(血液灌流联合血液透析)治疗重症心力衰竭合并肾功能衰竭患者临床疗效好,安全性高.疗效观察指标容易采取且简便易行.
目的 探討重癥心力衰竭閤併腎功能衰竭應用全血預遲透析管路後血液灌流聯閤血液透析治療後的療效.方法 選擇2007年6月至2009年6月牡丹江市第一人民醫院腎內科和心內一科重癥心力衰竭閤併腎功能衰竭患者48例.應用全血預遲透析管路後血液灌流聯閤血液透析治療.每天1次,連續3 d.每次治療前、後分彆觀察患者動脈血氣分析(碳痠氧根離子、pH值、動脈血氧飽和度、動脈血氧分壓、腎功能(血尿素氮、血肌酐)、血紅蛋白、呼吸、心率、平均動脈壓、中心靜脈壓水平.治療前和第3次治療後分彆觀察患者腩鈉素、腫瘤壞死因子α水平及左室舒張未期內徑、左室收縮末期內徑、左室射血分數.結果 治療過程中患者生命指標和血流動力學穩定.全部患者在治療期間無一例死亡.治療過程中生命指徵平穩,第1次治療後呼吸、心率、血紅蛋白、中心靜脈壓、碳痠氫根離子、pH值、動脈血氧飽和度、動脈血氧分壓、血尿素氮、血肌酐指標比較差異有統計學意義(P<0.05);平均動脈壓治療前、後比較差異無統計學意義(P>0.05);肺部濕啰音明顯減少,尿最逐漸增加.經3次治療後腦鈉素、腫瘤壞死因子α水平顯著下降,左室舒張末期內徑、左室收縮末期內徑、左室射血分數顯著改善(P<0.01).結論 血液預遲透析管路(血液灌流聯閤血液透析)治療重癥心力衰竭閤併腎功能衰竭患者臨床療效好,安全性高.療效觀察指標容易採取且簡便易行.
목적 탐토중증심력쇠갈합병신공능쇠갈응용전혈예충투석관로후혈액관류연합혈액투석치료후적료효.방법 선택2007년6월지2009년6월모단강시제일인민의원신내과화심내일과중증심력쇠갈합병신공능쇠갈환자48례.응용전혈예충투석관로후혈액관류연합혈액투석치료.매천1차,련속3 d.매차치료전、후분별관찰환자동맥혈기분석(탄산양근리자、pH치、동맥혈양포화도、동맥혈양분압、신공능(혈뇨소담、혈기항)、혈홍단백、호흡、심솔、평균동맥압、중심정맥압수평.치료전화제3차치료후분별관찰환자남납소、종류배사인자α수평급좌실서장미기내경、좌실수축말기내경、좌실사혈분수.결과 치료과정중환자생명지표화혈류동역학은정.전부환자재치료기간무일례사망.치료과정중생명지정평은,제1차치료후호흡、심솔、혈홍단백、중심정맥압、탄산경근리자、pH치、동맥혈양포화도、동맥혈양분압、혈뇨소담、혈기항지표비교차이유통계학의의(P<0.05);평균동맥압치료전、후비교차이무통계학의의(P>0.05);폐부습라음명현감소,뇨최축점증가.경3차치료후뇌납소、종류배사인자α수평현저하강,좌실서장말기내경、좌실수축말기내경、좌실사혈분수현저개선(P<0.01).결론 혈액예충투석관로(혈액관류연합혈액투석)치료중증심력쇠갈합병신공능쇠갈환자림상료효호,안전성고.료효관찰지표용역채취차간편역행.
Objective To investigate the effect of Hemoperfusion(HP) treatment preconditioning whole blood for the dialyzer on the severe congestive heart failure complicated renal failure.Methods 48 congestive heart failure complicated renal failure patients were randomly selected of in-patients in Department of Nephrology and first Cardiology First People's Hospital of Mudanjiang City during June 2007-June 2009.The hemoperfusion (HP) combined with hemodialysis(HD) treatment preconditioning whole blood for the dialyzer was applicated Once a day for 3 days.Observe the changes of indexes including arterial blood gas analysis (HCO3,pH,SaO2,PaO2),renal function (BUN,Scr),respiratory (RR),heart rate (HR),mean arterial pressure (MAP),central venous pressure and brain natriuretic peptide (BNP),tumor necrosis factor-α(TGFα),hemoglobin (Hb) levels before and after treatment every day.The changes of left ventricular end-diastolic diameter (LVEDD),left ventricular end systolic diameter (LVESD),left ventricular ejection fraction (LVEF) before and after treatment were observed in echocardiography every day.Result the vital indexes and hemedynamics of patients were stable in the course of treatment.None was dead in the course of treatment. The indicators of RR,HR,Hb,central venous pressure,SaO2,arterial blood gas analysis was improved significantly (P > 0.05).The patient's lung moist tales significantly reduced,urine output gradually increased.TNF-α decreased significantly after the first treatment( P < 0.05).The indicators of cardiac function:LVEDD,LVESD,LVEF improved significantly after the first treatment(P <0.05).Conclusion Hemoperfusion (HP)combined with hemodialysis(HD)treatment preconditioning whole blood for the dialyzer on the severe congesfive heart failure complicated renal failure has a good efficacy.the treatment has high safety.observation indexes was easy to take,simple accurate.